Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | ANPEP | P15144 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3774642 | 0.81 | MAPK1 (0.58) | NPC1RAB9APOLBMAPK1 | |
| SCHEMBL14380229 | 0.79 | MAPT (0.36) | PKMMAPTL3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL14423074 | 0.75 | ALDH1A1 (0.50) | L3MBTL1SMN1; SMN2ANPEPLMNANPC1 | |
| SCHEMBL1987585 | 0.73 | TSHR (0.49) | PKMSMN1; SMN2ANPEPLMNARAB9A | |
| SCHEMBL8440042 | 0.73 | RAB9A (0.32) | PKMMAPTL3MBTL1SMN1; SMN2NPC1 | |
| SCHEMBL12263896 | 0.72 | ATM (0.40) | PKMMAPTL3MBTL1SMN1; SMN2ANPEP | |
| SCHEMBL7019511 | 0.72 | HSD17B10 (0.58) | PKMMAPTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL14523918 | 0.72 | LMNA (0.45) | PKMMAPTL3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL14364836 | 0.72 | TDP1 (0.49) | PKMMAPTSMN1; SMN2LMNANPC1 | |
| SCHEMBL273890 | 0.72 | TDP1 (0.49) | PKMMAPTSMN1; SMN2LMNANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1678141-B1 | 1,3-DIMETHYLBUTYL CARBOXANILIDES FOR CONTROLLING UNDESIRABLE MICRO-ORGANISMS | BAYER CROPSCIENCE AG (DE) | 2014-02-12 | — | — | EP | disclosed |
| EP-2192115-B1 | 1,3-DIMETHYLBUTYLCARBOXANILIDES FOR CONTROLLING UNDESIRABLE MICRO-ORGANISMS | BAYER CROPSCIENCE AG (DE) | 2014-02-12 | — | — | EP | disclosed |
| EP-2192115-A1 | 1,3-dimethylbutylcarboxanilides for controlling undesirable micro-organisms | Bayer CropScience AG (DE) | 2010-06-02 | — | — | EP | disclosed |
| US-20070196406-A1 | 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms | BAYER CROPSCIENCE AG (DE) | 2007-08-23 | — | — | US | disclosed |
| EP-1678141-A1 | 1,3-DIMETHYLBUTYL CARBOXANILIDES FOR CONTROLLING UNDESIRABLE MICRO-ORGANISMS | Bayer CropScience Aktiengesellschaft (DE) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005042492-A1 | 1,3-DIMETHYLBUTYL CARBOXANILIDES FOR CONTROLLING UNDESIRABLE MICRO-ORGANISMS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2005-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196406-A1 | 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms | MCRS1, MRM1, PADI1 | PKM 1117/4885MAPT 3644/4885L3MBTL1 292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.